Evidence for the existence of different receptor sites for algesic agents at the endings of muscular group IV afferent units.
The hypothesis that different receptor sites for algesic agents exist at free nerve endings in skeletal muscle has been tested by administering bradykinin and 5-hydroxytryptamine (5-HT) repeatedly in anaesthetized cats and evaluating the response behaviour of single group IV afferent units from the gastrocnemius-soleus muscle. Repeated intraarterial administration of bradykinin at intervals of 1 and 2 min usually elicited fibre responses without tachyphylaxis. Injections of equieffective doses of 5-HT, however, given in the same manner evoked fibre reactions that were strongly tachyphylactic. In units responding to both bradykinin and 5-HT a refractoriness to 5-HT could be induced by repeated injections of this agent without impairing the stimulating potency of bradykinin on the same nerve ending. Such a lack of cross-tachyphylaxis seems to apply also to the effects of histamine on one side and bradykinin or 5-HT on the other. These findings suggest that bradykinin, 5-HT and probably histamine exert their excitatory action on muscular group IV afferent units via different receptor sites.
D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D004594:Electrophysiology; D006632:Histamine / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D007273:Injections, Intramuscular; D009132:Muscles / Q000294:innervation*; D009411:Nerve Endings / Q000648:ultrastructure*; D009475:Neurons, Afferent / Q000502:physiology; D010146:Pain; D011955:Receptors, Drug; D011984:Sensory Receptor Cells / Q000648:ultrastructure*; D012701:Serotonin / Q000494:pharmacology; D013618:Tachyphylaxis
D011955:Receptors, Drug; D012701:Serotonin; D006632:Histamine; D001920:Bradykinin